STOCK TITAN

Aberdeen Group Files 13G for 2.23M SERA Shares, 6% Ownership

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Aberdeen Group plc and its U.S. affiliate abrdn Inc. have filed a Schedule 13G disclosing a passive ownership stake in Sera Prognostics (SERA).

  • Shares owned: 2,227,367 Class A common shares.
  • Ownership percentage: 6.07% of the outstanding class as of 30 Jun 2025.
  • Voting & dispositive power: 0 shares held with sole power; all 2,227,367 shares held with shared voting and dispositive power by both reporting entities.
  • Reporting parties: Aberdeen Group plc (UK parent, classified as a Holding Company – “HC”) and abrdn Inc. (US subsidiary, classified as Corporation & Investment Adviser – “CO, IA”).
  • Intent: Certification states the position is held in the ordinary course of business and is not intended to influence or control the issuer.
  • Structure: Aberdeen Group plc → abrdn Holdings Ltd. → abrdn Inc.; the U.S. adviser holds the shares for underlying clients.

The filing indicates that a sizable institutional investor has surpassed the 5 % threshold, triggering disclosure under Rule 13d-1(b). No changes to company control or strategic direction are signaled.

Positive

  • Institutional ownership exceeds 6 %, indicating increased professional investor interest in SERA.
  • Position classified as passive, reducing risk of disruptive activist activity while still adding shareholder support.

Negative

  • None.

Insights

TL;DR: abrdn reveals 6 % passive stake, adding institutional support without control ambitions; market impact likely modest but positive sentiment.

The 13G shows an international asset manager allocating client capital to SERA, a small-cap diagnostics name. A 6.07 % position is meaningful for liquidity yet remains below 10 %, so no activist overtones. Shared rather than sole voting/dispositive power confirms the stake is aggregated across managed accounts. For existing shareholders the disclosure improves the free-float quality, potentially lowering volatility and enhancing analyst attention. However, as a passive filing, it carries no direct catalyst for operational change or takeover speculation. Impact is therefore mildly constructive but not transformational.

TL;DR: Filing signals compliance and transparency; no governance pressure expected.

Because Aberdeen/abrdn filed on Form 13G rather than 13D, they certify no intent to influence control. The filing complies with §240.13d-1(b) and includes clear breakdown of voting power, supporting SERA’s governance stability. Investors should not anticipate board nominations or policy proposals from this holder. The presence of a reputable UK-based institution may nonetheless enhance governance credibility and facilitates future capital raises by diversifying the shareholder register.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Aberdeen Group plc
Signature:C. Cole
Name/Title:Chris Cole/ Senior Major Shareholding Reporting Analyst
Date:08/05/2025
abrdn Inc.
Signature:C.Cole
Name/Title:Chris Cole/ Senior Major Shareholding Reporting Analyst
Date:08/05/2025
Exhibit Information

Aberdeen Group plc abrdn Holdings Limited abrdn Inc. Aberdeen Group plc is the parent company. abrdn Holdings Limited is the intermediate holding company for abrdn Inc. abrdn Inc. beneficially owns on behalf of our underlying clients 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G.

FAQ

How many SERA shares does abrdn Inc. own?

The Schedule 13G lists 2,227,367 Class A shares held with shared voting and dispositive power.

What percentage of Sera Prognostics does Aberdeen Group plc control?

Aberdeen Group plc and affiliates report 6.07 % of the outstanding Class A common stock.

Is the abrdn stake in SERA activist or passive?

Filed on Schedule 13G, the stake is passive; the filers certify no intent to influence control.

When was the ownership level triggering disclosure reached?

The event date requiring this filing is 30 June 2025.

What are the voting rights associated with the disclosed SERA shares?

Both entities have shared voting and dispositive power over all 2,227,367 shares; no sole power is held.
Sera Prognostics, Inc.

NASDAQ:SERA

SERA Rankings

SERA Latest News

SERA Latest SEC Filings

SERA Stock Data

88.38M
33.45M
Medical Devices
Services-medical Laboratories
Link
United States
SALT LAKE CITY